The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease.
Inflamm Bowel Dis
; 18(1): 112-9, 2012 Jan.
Article
in En
| MEDLINE
| ID: mdl-21351217
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Colitis
/
Antimicrobial Cationic Peptides
/
Bone Morphogenetic Protein 6
/
Anti-Bacterial Agents
Type of study:
Etiology_studies
Limits:
Animals
Language:
En
Journal:
Inflamm Bowel Dis
Journal subject:
GASTROENTEROLOGIA
Year:
2012
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom